Skip to content

Technology
Pipeline
About Us
News
Investors
Contact

Technology
Pipeline
About Us
News
Investors
Contact

Press Releases

news hero image

Choose Year
Search Press Releases

Found 33 Results

April 13, 2021

Nasus Pharma announces positive Results in Naloxone Pivotal Trial.

«1 2 3 45

IR Contact

Mike Moyer
LifeSci Advisors
617-308-4306
IR@nasuspharma.com

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Unsubscribe

Loading...

Science

Technology
Pipeline
NS003 Ondansetron
NS002 Epinephrine
NS001 Naloxone
Publications

Company

About us
Leadership
Board of Directors
Advisory Board
Contact

Investors

Investors Overview
Press Releases
Events
SEC Filings
Company Reports
Corporate Governance
Stock Information
Investor FAQs

© 2026 Nasus Pharma All rights reserved

Accessibility Statement
Cookies Policy
Privacy Policy
Terms And Conditions Of Use

Scroll to Top